DrugPatentWatch Database Preview
Profile for United States of America Patent: 2014179721
US Patent Family Members and Approved Drugs for United States of America Patent: 2014179721
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Aug 25, 2024 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Aug 25, 2024 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Aug 25, 2024 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Aug 25, 2024 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |